ArticleBioMed research international2019

Etifoxine, a TSPO Ligand, Worsens Hepatitis C-Related Insulin Resistance but Relieves Lipid Accumulation.

Yu-Min Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.